TraceLink Hosts Conference Centered Around E2E Supply Chain Visibility
DSCSA compliance was also top of mind at the event.
Image Credit: Adobe Stock Images/Parradee
TraceLink Inc., a digital network platform company that works extensively with members of the pharma supply chain, has wrapped this year's FutureLink conference with attendees reportedly leaving the event confident in their ability to meet the final Drug Supply Chain Security Act (DSCSA) compliance requirements, while also learning how to drive better end-to-end (E2E) visibility, collaboration, and intelligence across the supply chain.
Notable highlights included TraceLink president and CEO Shabbir Dahod, who outlined the formula for supply chain digitalization developed through global track-and-trace compliance success; a fireside chat with Optum’s VP of supply chain and engineering Bryan Rabakon that discussed emerging opportunities to address drug shortages by leveraging supply chain intelligence; and a discussion with Eric Marshall, executive director of the Partnership for DSCSA Governance (PDG) to review PDG's DSCSA interoperability blueprints and key learnings from industry leaders on DSCSA November 2023 preparations.
" … The continued investments made to meet DSCSA and global serialization and traceability regulations have created an incredible digital network foundation for companies to improve visibility, predictability, and agility by digitalizing supply transactions with all supply and trade partners,” says Dahod. “It was energizing to talk with attendees and hear their ideas for how these new end-to-end digitalization capabilities can help address critical challenges, like predicting drug shortages and de-risking interoperable information exchange across a range of regulatory and value-based supply chain processes."
